期刊文献+

2-[4-(4-氟苄基)哌嗪-1-基甲基]吡唑并[1,5-a]吡啶的合成及其体外受体结合分析

Synthesis of 2-[4-( 4-Fluorobenzyl) piperazin-1-ylmethyl]pyrazolo [1,5-a]pyridine and Its in vitro Receptor Binding Assay
下载PDF
导出
摘要 以吡唑并[1,5-a]吡啶-2-甲醛和N-甲酰基哌嗪为原料,经过还原胺化反应、水解反应、N-烷基化反应,合成了2-[4-(4-氟苄基)哌嗪-1-基甲基]吡唑并[1,5-a]吡啶,总收率29.5%,用1HNMR、19FNMR、ESI-MS对中间体及目标化合物进行了结构表征,并通过体外受体结合实验,测定目标化合物对多巴胺D4受体的亲和常数为1.2nmol/L,对D2、D3受体的亲和常数分别为3 900、1 890 nmol/L,显示对多巴胺D4受体具有较高的亲和性与选择性,是一种潜在的多巴胺D4受体配基。 2-[ 4-(4-Fluorobenzyl) piperazin-l-ylmethyl] pyrazolo[ 1,5-a] pyridine was synthesized from pyrazolo[ 1,5-a] pyridine-2-carbaldehyde and 1-piperazineearboxaldehyde through reductive amination, amide hydrosis and N-alkylation. The structures of the intermediates and the target compound were confirmed by ^1HNMR,^19 FNMR and ESI-MS. Through in vitro receptor binding assay, the affinity constants of the target compound were determined to be 1.2,3 900 and 1 890 nmo]/L for D4, D2, and D3 receptor, respectively, which indicates that 2- [ 4- (4-fluorobenzyl) piperazin-1 -ylmethyl ] pyrazolo [ 1, 5-a ] pyridine is a potential dopamine D4 receptor ligand.
出处 《精细化工》 EI CAS CSCD 北大核心 2013年第8期932-935,共4页 Fine Chemicals
基金 湖南省科技计划项目(2012FJ4343)~~
关键词 吡唑并[1 5-a]吡啶 多巴胺D4受体 配基 体外结合分析 医药与日化原料 pyrazolo [ 1,5-a ] pyridine dopamine D4 receptor ligand in vitro binding assay drug andcosmetic materials
  • 相关文献

参考文献14

  • 1Ehlicht K,Gotz A,Bollinger S,et al. Dopamine D2 ,D3 and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding [ J ]. J Med Chem, 2009,52 ( 15 ) :4923 - 4935.
  • 2Pawel Z, Krzysztof M, Andrzej M ,et al. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi- receptor-5-HT1A/5-HT2n/5-HT7 and Da/D3/D4-agents: the synthesis and pharmacological evaluation [ J ]. Bioorgan Med Chem,2012,20 : 1545 - 1556.
  • 3Takami G, Ota M, Nakashima A, et al. Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase [ J 1. J Neural Transm,2010,117 (10) :1139 - 1153.
  • 4Rostom S A. Novel fused pyrrole heterocyclic ring systems as structure analogs of LE 300: synthesis and pharmacological evaluation as serotonin 5-HTzA, dopamine and histamine H1 receptor ligands[ J]. Arch Pharm ,2010,343 (2) :73 - 80.
  • 5金国章.遐思:精神分裂症病因和药物治疗[J].中国处方药,2005(8):7-11. 被引量:5
  • 6Lauzon N M, Laviolette S Pt. Dopamine D4 -receptor modulation of cortical neuronal network activity and emotional processing: implications for neuropsychiatric disorders [ J ]. Behav Brain Res, 2010,208(1) :12 -22.
  • 7Stefan L, Harald H, Peter G. Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype [ J]. Bioorg Medicinal Chem Letter, 2006, 16 ( 11 ) :2955 - 2959.
  • 8Iris R, Gottfried S. Dopamine D4 receptor exon Ⅲ polymorphism, adverse life events and personality traits in a nonclinical German adult sample[ J]. Neuropsycholoiology,2011,63 ( 1 ) :52 - 58.
  • 9Linz S, M(iler J, Hiiner H, et aL Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases [ J ]. Bioorgan Med Chem, 2009,17 ( 13 ) : 4448 - 4458.
  • 10李谷才,尹端沚,夏姣云,汪勇先.3-(4-羟基苄基)-8,9-二甲氧基-1,2,3,4-四氢苯并吡喃[3,4-c]吡啶-5-酮的合成[J].精细化工,2005,22(9):694-695. 被引量:1

二级参考文献13

  • 1Jablensky A.Epidemiology of schizophrenia:the global burden of disease and disability[J].Eur Arch Psychiatry Clin Neurosci,2000,250(6):274-285.
  • 2Seeman P.Antipsychotic drugs,dopamine receptors,and schizophrenia[J].Clinical Neuroscience Research,2001,1:53-60.
  • 3Ou Bai,Hong-hong Zhang,Xin-min Li.Antipsychotic drugs clozapine and olanzapine upregulate bc1-2 mRNA and protein in rat frontal cortex and hippocampus[J].Brain Research,2004,1010:81-86.
  • 4Jürgen Einsiedel,Harald Hübner,Peter Gmeiner.Cylic amidines as benzamide bioisosteres:EPC synthesis and SAR studies leading to the selective D4 receptor agonist FAUC 312[J].Bioorganic & Medicinal Chemistry Letters,2003,13:851-854.
  • 5Mark H Corrigan,Christopher C Gallen,M Luisa Bonura,et al.Effectiveness of the selective D4 antagonist sonepiperazole in schizophrenia:a placebo-controlled trail[J].Biological Psychiatry,2004,55:445-451.
  • 6Hai-Bin Tian,Duan-Zhi Yin,Lan Zhang,et al.Synthesis and biological evaluation of 3-{[4-[18F]fluorophenyl]methyl} piperazin-1-yl}methyl-1H-pyrrolo[2,3-b]pyridine for in vivo studies of dopamine D4 receptor[J].Journal of Radioanalytical and Nuclear Chemistry,2004,262(2):383-389.
  • 7Paul C Unangst,Thomas Capiris,David T Connor,et al.Chromeno[3,4-c]pyridin-5-ones:selective human dopamine D4 receptor antagonists as potential antipsychotic agents[J].J Med Chem,1997,40:2688-2693.
  • 8Goff DC,Coyle JT.The emerging role of glutamate in the pathophysiology and treatment of schizophrenia[].American Journal of Psychiatry.2001
  • 9William GV,Goldman-Rakic.Modulation of memory fields by dopamine D1 receptors in prefrontal cortex[].Nature.1995
  • 10Okubo Y.Decreased prefrontal dopamine D1R receptor in schizophrenia revealed by PET[].Nature.1997

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部